XTSEKPT
Market cap55mUSD
Jan 09, Last price
8.03CAD
1D
-1.47%
1Q
-3.02%
Jan 2017
-48.76%
IPO
-53.72%
Name
KP Tissue Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
8.71%
Shrs. gr., 5y
1.33%
Rev. gr., 5y
%
Revenues
0k
Net income
-5m
L-51.83%
CFO
7m
+5.55%
Dividend
Sep 27, 20240.18 CAD/sh
Earnings
Mar 05, 2025
Profile
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
IPO date
Dec 12, 2012
Employees
2,700
Domiciled in
CA
Incorporated in
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | 4,107 | (2,298) | |||||||
Tax Rate | |||||||||
NOPAT | (4,107) | 2,298 | |||||||
Net income | (4,937) -51.83% | (10,249) -927.20% | |||||||
Dividends | (6,984) | (6,617) | |||||||
Dividend yield | 7.78% | 6.57% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (68,162) | (79,338) | |||||||
| Cash flow | |||||||||
Cash from operating activities | 6,984 | 6,617 | |||||||
CAPEX | |||||||||
Cash from investing activities | 6,984 | 6,617 | |||||||
Cash from financing activities | (6,984) | (6,617) | |||||||
FCF | (1,522) | (2,532) | |||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | 68,162 | 79,338 | |||||||
Excess cash | 68,162 | 79,338 | |||||||
Stockholders' equity | (92,467) | (70,789) | |||||||
Invested Capital | 160,824 | 144,819 | |||||||
ROIC | 1.59% | ||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 9,956 | 9,936 | |||||||
Price | 9.02 -11.05% | 10.14 -2.59% | |||||||
Market cap | 89,803 -10.87% | 100,753 -1.60% | |||||||
EV | 21,641 | 21,415 | |||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||